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INTRODUCTION
Retroperitoneal bleeding is a rare complication of an-
ticoagulant therapy. The clinical consequences depend on
the rate of blood loss and on the total amount of blood that
is lost into the retroperitoneum.1 Once diagnosed, this con-
dition requires immediate suspension of the anticoagulant,
correction of the coagulation disorders and fluid restora-
tion.1,2
CASE DESCRIPTION
 A 49-year-old female patient was admitted to hospital
complaining of progressive and severe abdominal pain for
the past 3 days. She had been taking warfarin due to a prior
diagnosis of deep venous trombosis of the lower extremi-
ties. Upon admission her abdomen was mildly distended,
her intravesical pressure (IVP) was 45 cm H2O and her
blood pressure (initially 70/40 mmHg) rose to 110/80
mmHg after rapid administration of 1000ml of saline so-
lution. The blood count ordered upon her arrival showed a
hemoglobin level of 4.1g/d, and an international normal-
ized ratio (INR) of 4.4. CT of the abdomen and pelvis
showed a large retroperitoneal and pelvic hematoma [fig-
ure 1]. Initially, a conservative approach was adopted: the
patient received 1200ml of packed red cells (PRC), 1000ml
of fresh frozen plasma and 3500ml of crystaloid solution.
However, after the first 12 hours of observation she devel-
oped oliguria, seizures, shock and respiratory failure. Se-
rial physical examinations revealed marked abdominal dis-
tension and IVP rose to 60cm H2O. The clinical picture re-
sembled abdominal compartment syndrome (ACS) and a
decision for decompressive laparotomy was made. As soon
as the abdominal cavity was opened the ventilatory and
hemodynamic parameters improved significantly, which
confirmed ACS. A large retroperitoneal hematoma was seen
but not explored, since the purpose of the procedure was
only for decompression. A laparostomy with a Bogotá bag
was performed [figure 2] and the patient was sent to the
intensive care unit where she stayed for 12 days, with pro-
gressive improvement in hemodynamic and ventilatory pa-
rameters. During this period she received another 600ml
of PRC and by the 10th day all coagulation parameters were
in the normal range. She then underwent serial closure of
the laparostomy according to our service protocol and by
the end of 29 days the abdomen was totally closed. A du-
plex scan confirming deep venous thrombosis of the left
lower extremity was ordered after internal medicine and
vascular surgery consultations. Because the patient had not
had an episode of pulmonary embolism and because inad-
equate control of anticoagulation was considered to be the
probable cause of the retroperitoneal hematoma, systemic
anticoagulation with heparin was reintroduced. As an out-
patient she was kept on warfarin for another 6 months with-
out any further bleeding complications.
DISCUSSION
Oral anticoagulants have had an expanding role in car-
diovascular and thrombotic disorders. Major indications for
warfarin use are nonvalvular atrial fibrillation, venous
thrombosis, rheumatic heart disease, mechanical heart valve
prosthesis, and pulmonary, cerebral or systemic embolism.3-5
Warfarin therapy is associated with a variety of
hemorrhagic complications that are usually associated with
inadequate control of anticoagulation.2 This is probably
what happened to the patient reported above, since her INR
was 4.4. Spontaneous retroperitoneal hematomas are rare;
Brathwaite CE et al. described only one case of a retro-
peritoneal hematoma out of 13 patients that required ter-
mination of anticoagulation due to hemorrhagic complica-
tions6. Stephan D and colleagues evaluated 928 patients that
were on chronic anticoagulation with warfarin in a retro-
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spective cohort study. They found an incidence of first
bleeding episodes of 17.3 events/100 patient-years for mi-
nor bleeding, 7.5 events/100 patient-years for serious bleed-
ing, 1.1 events/100 patient-years for life-threatening bleed-
ing and 0.2 events/100 patient-years for fatal bleeding5.
Four variables demonstrated an independent relation to the
risk of a first episode of bleeding according to this study:
mean prothrombin time ratio (PTR) of 2.0 or greater, short
duration anticoagulation (during the first three months of
anticoagulation therapy, the risk of bleeding is higher than
after the forth month), high PTR variability and the pres-
ence of three or more comorbid conditions.5 Another study
showed an incidence of major bleeding in patients treated
with coumarin derivatives of 1.4 per 100 patient-years.7
Abnormal and sudden increase in the volume of any
component of the intra-peritoneal or extra-peritoneal spaces
can cause intraperitoneal hypertension.8 When associated
with organ dysfunction (elevated airway pressure, cardiac
output reduction, and oliguria) it meets the criteria for
ACS.9,10 This usually occurs when the intra-abdominal pres-
sure, measured by IVP, is above 20-25 cm H2O.9,11 The vol-
ume increase is mainly due to abdominal trauma, but may
also be caused by significant intra-abdominal bleeding or
collections, retroperitoneal hematomas, difuse peritonitis,
peritoneal edema due to vigorous volemic ressucitation,
packing of the abdominal cavity (damage control), pancrea-
titis, pneumoperitoneum and neoplasms.11-13 Treatment con-
sists of prompt surgical decompression and volemic resus-
citation.8,10-14 The mortality rate varies from 29 to 62% and
is usually due to multiple organ failure and sepsis.10,14,15
In regard to the case presented above, a nonoperative
approach to a retroperitoneal hematoma was attempted first.
However, after fluid and blood replacement, the patient pre-
sented with a full-blown clinical picture of ACS, which led
to a straightforward decision for a laparostomy.
A review of the literature reveals little data regarding
the duration of withholding warfarin, subsequent throm-
boembolic complications, and the risk of rebleeding on re-
sumption of warfarin treatment in these patients.
Ananthasubramaniam K et al. studied these considerations
in patients with prosthetic heart valves hospitalized with a
major bleeding event. The mean duration of warfarin with-
holding during hospitalization in their study was 15 ± 4
days and none of their patients received other
antithrombotic therapies during hospitalization. All of their
patients resumed warfarin therapy when they were deemed
stable by their primary physicians and did not have any
Figure 1 - Computed tomography showing a large retroperitoneal hematoma, shifting the rectum and bladder to the right.
Figure 2 - Laparostomy
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thromboembolic events or significant rebleeding episodes.16
Little data exist about recurrent bleeding after resumption
of warfarin therapy, but it appears to be common within 5
months of the resumption of anticoagulation. Those whose
first bleeding was from a gastrointestinal source are par-
ticularly at risk for a second event.5,16 Aggressive treatment
of the bleeding source and the risk-benefit ratio of contin-
ued anticoagulation need to be considered. An alternative
for these high risk rebleeding patients is early caval filter
placement.6
In conclusion, a large retroperitoneal hematoma is a se-
vere and potentially fatal complication of anticoagulant
therapy. Patients with this sort of complication require con-
stant monitoring of hemodynamic and ventilatory param-
eters, diuresis and intravesical pressure, since they are at
risk for developing ACS.
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